Delivery Order SPE2DB25D3201-SPE2DB25FNSGL
Award Date
4/8/25
Potential Completion Date
4/9/25
Potential Value
$6.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,195.01, is for the delivery of RYTARY ER 36.25 MG-145 MG CAP 100S, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of June 26, 2024. This award is not associated with a set-aside program. AmerisourceBergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,848.65, is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a prescription pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of February 11, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,187.74, is for the delivery of RYTARY ER 36.25 MG-145 MG capsules. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of July 19, 2024. The contract does not have a set-aside designation, indicating it was open to full and open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,155.82, is a delivery order for the supply of RYTARY ER 61.25 MG-245 MG CAP 100S, a pharmaceutical product. The contract has an ultimate completion date of February 4, 2025 and is a firm fixed-price contract. This order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYTARY ER 36.25 MG-145 MG CAP 100S, a pharmaceutical product, with a ceiling value of $2,021.71 and a completion date of March 25, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,934.65, is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 20, 2023. There is no set-aside designation mentioned in the information provided....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,814.95, is a firm fixed-price delivery order for the pharmaceutical product RYTARY ER 36.25 MG-145 MG CAP 100S. The contract has an ultimate completion date of November 13, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $28,874.37, is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,011.48, is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,973.90, is for the delivery of RYTARY ER 36.25 MG-145 MG capsules in quantities of 100. The contract is a Firm Fixed Price Delivery Order, with a period of performance through March 26, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...